| Miracle Kids Success Academy | |
|
200 General St, Batesville, AR 72501-9407 | |
| (870) 793-3200 | |
| Not Available |
| Full Name | Miracle Kids Success Academy |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 200 General St, Batesville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699096214 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Miracle Kids Success Academy 200 General St, Batesville, AR 72501-9407 Ph: (870) 793-3200 | Miracle Kids Success Academy 200 General St, Batesville, AR 72501-9407 Ph: (870) 793-3200 |
News Archive
Stimulating the visual cortex of the brain for 20 minutes with a mild electrical current can improve vision for about two hours, and those with worse vision see the most improvement, according to a Vanderbilt University study published this week in Current Biology.
Any science textbook will tell you we can't see infrared light. Like X-rays and radio waves, infrared light waves are outside the visual spectrum.
As e-cigarette usage among high school students continues to climb, a recent study from The Journal of the American Medical Association reveals an unsettling trend: that adolescent e-cigarette users are more likely than their non-vaping peers to initiate use of combustible tobacco products such as cigarettes, cigars and hookahs. The reason may lie in a common denominator between e-cigarettes and their combustible counterparts: nicotine.
Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.
› Verified 8 days ago
Mrs. Shelley Pfitzner, MDC, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3334 Fax: 870-793-3474 | |
Mrs. Jill Overturf, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3334 Fax: 870-793-3474 | |
Chelsea Sanderson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 Allen St, Batesville, AR 72501 Phone: 870-793-2877 | |
Christine Wilkerson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1271 Fax: 870-262-6013 | |
Taylor Mynatt, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1000 White Drive, Batesville, AR 72501 Phone: 870-793-2877 | |
Mrs. Jennifer K. Harmon, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 70 Scott Dr, Batesville, AR 72501 Phone: 870-251-2341 Fax: 870-251-3316 | |
Sarah Poole, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2955 Juniper Dr, Batesville, AR 72501 Phone: 870-613-9006 |